Introduction
The thyroid gland produces two related hormones, thyroxin (T4) and triiodothyronine (T3). Acting through thyroid hormone receptors α and β, these hormones plays a critical role in cell differentiation during development and help maintain thermogenic and metabolic homeostasis in the adult. Autoimmune disorders of the thyroid gland can stimulate overproduction of thyroid hormones (thyrotoxicosis) or cause glandular destruction and hormone deficiency (hypothyroidism) [1] . Primary hypothyroidism is due to disease in the thyroid; thyroid-stimulating hormone (TSH) is increased. The most common cause is autoimmune. Primary hypothyroidism is due to disease in the thyroid; thyroid-stimulating hormone (TSH) is increased. The most common cause is autoimmune. It usually results from Hashimoto thyroiditis and is often associated with a firm goiter or, later in the disease process, with a shrunken fibrotic thyroid with little or no function. [2] Primary hypothyroidism is an endocrine disorder which affects many organs of which musculoskeletal involvement is one of the important disease manifestations. Cause of overlap between hypothyroidism and rheumatic diseases could be probably because of autoantibodies. At the molecular level probable mechanism is auto-reactive T cells which recognize auto antigens expressed on thyroid tissue and other organs. [3] . Genetic factors also contribute to the occurrence of RA. The alleles known to confer the greatest risk of RA are located within the major histocompatibility complex (MHC). It has been estimated that onethird of the genetic risk for RA resides within this locus. Most, but probably not all, of this risk is associated with allelic variation in the HLA-DRB1 gene, which encodes the MHC II β-chain molecule [4] thus common genetic predisposition between AITD and RA could be one of the reason for there co existence in many patients.In this study prevalence of rheumatoid arthritis among 200 hypothyroid patient was found to be 24.5% including 18.5% of females and 6% males which is supported by study conducted by other authors too [5, 6] Osteoarthritis (OA) isn't caused by immune system issues. Emerging evidence has identified genetic mutations that confer a high risk of OA, the best replicated is a polymorphism within the growth differentiation factor 5 gene. This polymorphism diminishes the quantity of GDF5; GDF5 has its main influence on joint shape, and genes predisposing to OA are likely to increase risk of disease based on their effects on joint development and shape [7] , although pathogenesis of both AITD and OA are different but there co existence in patients are quite common. Prevalence of osteoarthritis in study population is 55% and highest prevalence is in 51-60 yrs age group i.e. 71.23%. Prevalence in female is 47% as compared to male 8%. supported by previous study by Alakes Kumar Kole, Rammohan Roy, Dalia Chanda Kole [8] Older women are at high risk of OA in all joints, a risk that emerges as women reach their sixth decade .In this study out of 94 hypothyroid females having osteoarthritis, 56 were in the age group between 51-60 years that is in 6 th decade which depicts, that as the women reach near menopausal age prevalence of osteoarthritis increases, this is probably due to decline in oestrogen levels after menopause. BMI is also positive contributory factor for the development of Osteoarthritis which is also proved by this study, having max 54 patients with BMI ranging in overweight category (BMI 25-29.9 Kg/m 2 ) out of total 110 osteoarthritis individuals. Systemic lupus erythematosus (SLE) is an autoimmune disease in which organs and cells undergo damage initially mediated by tissuebinding autoantibodies and immune complexes. In most patients, autoantibodies are present for a few years before the first clinical symptom appears. Ninety percent of patients are women of childbearing years; people of all genders, ages, and ethnic groups are susceptible [9] In this study 25 out of 200 hypothyroid patients had Systemic lupus erythematosus, 24 were females and 1 was male. Prevalence of SLE in study population was 12.5% and highest prevalence was seen in age group 20-30 years (77.78%). Prevalence in female was 12% as compared to male 1%, which is well in coherence with other studies conducted in past [10] Serological overlap among SLE, and AITD exists [11] [12] [13] [14] that might be the reason for their association.
Patients with fibromyalgia have reduced pain tolerance to stimuli that are normally not painful such as pressure, heat, and electric pulse, at the classic tender points and control points (allodynia). They also perceive pain as being more intense and extending for a longer time (hyperalgesia). This abnormal sensory pain processing could be explained by increased pain facilitation and reduced pain-inhibiting mechanisms on the spinal and cerebral levels. Fibromyalgia patients also displayed abnormal temporal summation of pain after a series of thermal stimulations, called "wind-up." The concentration of substance P, a neuromodulator of pain, in the cerebrospinal fluid was threefold greater in fibromyalgia patients than in controls [15] . Thyroid hormone regulates substance P in discrete nuclei of the brain, in the anterior pituitary, in the lumbar spinal cord, and in the dorsal root ganglia. Most significantly, however, thyroid hormone directly regulates transcription of the preprotachykinin gene, which codes for preprotachyki-nin-A (the precursor of substance P) and the substance P receptor. Studies confirm the negative regulation of substance P by thyroid hormone: increasing the availability of thyroid hormone decreases levels of substance P; decreasing thyroid hormone increases levels of substance P [16] , that might be the possible reason for association between fibromyalgia and hypothyroidism, its prevalence in this study was 2.5%.All were females SSc shows modest heritability, and the genetic associations identified to date make only a small contribution to disease susceptibility. concordance for antinuclear antibody (ANA) positivity is significantly higher. The risk of Raynaud's phenomenon, interstitial lung disease, and other autoimmune diseases, including systemic lupus erythematosus (SLE) rheumatoid arthritis and autoimmune thyroiditis [17] . Its prevalence in study population was 1%, equal prevalence in both male and female (0.5%). Sjögren's syndrome is characterized by both lymphocytic infiltration of the exocrine glands and B lymphocyte hyperreactivity. An oligomonoclonal B cell process, which is characterized by cryoprecipitable monoclonal immunoglobulins (IgMκ) with rheumatoid factor activity, is evident in up to 25% of patients. [18] Prevalence of Sjogren's syndrome in study population was 1%. Jara L.J. et.al. [19] in their study found that, The coexistence of SS and thyroiditis is frequent and suggests a common genetic or environmental factor predisposition with similar pathogenic mechanisms. primary Sjögren's syndrome (pSS) was ten times more frequent in patients with autoimmune thyroid disease and autoimmune thyroiditis was nine times more frequent in pSS ANKYLOSING SPONDYLITIS is an inflammatory disorder of unknown etiology that primarily affects the axial skeleton; peripheral joints and extra-articular structures are also frequently involved. In this study 4 out of 200 had ankylosing spondylitis.3 patients were male and 1 was female, Prevalence of ankylosing spondylitis in study population is 2%, Prevalence in female is 0.5% as compared to male 1.5%. MCTD prevalence in this study was 1.5%, Prevalence in female was 1% as compared to male 0.5 %. Alkes koel (8) in their study found prevalence of MCTD 1.67% which is close to prevalence we concluded in this study, Arthropathy in hypothyroidism is Noninflammatory arthralgia, stiffness and arthritis. Arthritis is non-inflammatory, highly viscous joint effusions primarily affecting the knees, wrists and hands. The symptoms may mimic rheumatoid arthritis. Arthropathy can be treated with thyroid hormone replacement therapy. Adhesive capsulitis, also known as frozen shoulder, is a regional skeletal problem reported in association with thyroid disorders. In this study prevalence of myalgia was 71.5%, stiffness and muscle cramp-80%, Arthralgia-60%, Adhesive capsulitis-25%, carpel tunnel syndrome -8%, Trigger finger -7%, Tarsal tunnel syndrome-2%, Dupuytren's contracture -5% Back pain (non inflammatory) -30%.
Conclusion
Various musculoskeletal manifestations are commonly associated with hypothyroidism.
1. Among various musculoskeletal manifestations, most common is osteoarthritis followed by rheumatoid arthritis. 2. These musculoskeletal manifestations increase with the increasing in duration of hypothyroidism which can be indirectly correlated with the duration of drug intake.
3. These MSK manifestations are more common in female hypothyroid patients as compared to male hypothyroid patients 4. The prevalence of osteoarthritis increases as women reach menopausal age 5. Development of MSK disorders, such as Osteoarthritis is commonly associated with increased BMI. 6. Association of primary hypothyroidism with major rheumatic manifestations was as follows: a) Osteoarthritis -55% (maximum) b) RA -24% c) SLE -12.5% d) Fibromyalgia -2.5% , e) Ankylosing spondylitis -2%, f) MCTD-1.5%, g) Systemic sclerosis -1% h) Sjogren's syndrome 1%. The study emphasizes the role of thyroid status (hypothyroidism) in patients suffering from various rheumatic diseases. Early detection of hypothyroidism and its prompt treatment with thyroid replacement therapy can result into dramatic changes in alleviating the symptoms of disease and outcome.
